After immunoglobulin evaluation (IgG, IgA, IgM, and IgE) in all participants, four patients were diagnosed with de novo predominantly antibody deficiencies: Two with common variable immunodeficiency and two with selective IgA deficiency. This evidence concerns the gene CD79A and agammaglobulinemia.